# Tarsus Pharmaceuticals Revenue Climbs 63.9% to $194.5 Million in Q3

By John Kim

Canonical URL: https://www.tokenpost.com/news/business/48313
Published: 2026-11-04T07:06:38.000Z
Updated: 2026-11-04T07:06:38.000Z
Section: Business

> GAAP earnings per share was -$14.40. Cash, cash equivalents and marketable securities totaled $309.6 million as of Sept. 30.

Tarsus Pharmaceuticals' third-quarter revenue was $194.5 million, up 63.9% year over year.

GAAP earnings per share was -$14.40.

Cash, cash equivalents and marketable securities totaled $309.6 million as of Sept. 30.